Back | Next |
home / stock / ctso / ctso message board
Subject | By | Source | When |
---|---|---|---|
Avenir Corp Buys 132,235 Shares of Cytosorbents Co. (NASDAQ:$CTSO) | Good Sport | investorshub | 06/13/2023 8:48:27 PM |
Nobody asked me but that was a good | fantomphan | investorshub | 06/06/2023 7:28:53 PM |
Looks like blocks husband added to his retirement account | rdgere | investorshub | 05/30/2023 11:44:18 AM |
Intraoperative ticagrelor removal via hemoadsorption during on-pump coronary | andy55q | investorshub | 05/29/2023 10:43:32 AM |
No opinion at this time | andy55q | investorshub | 05/22/2023 2:27:51 PM |
Andy, any thoughts on where we are regarding | fantomphan | investorshub | 05/21/2023 1:43:38 PM |
Cost-Effectiveness and Budget Impact of a Novel Antithrombotic | andy55q | investorshub | 05/20/2023 11:42:19 AM |
Talking to a buddy yesterday and he told | Good Sport | investorshub | 05/19/2023 6:08:27 PM |
Now that is a very good sign. | Cytobeliever | investorshub | 05/13/2023 7:10:52 PM |
Love it | Jdizzy | investorshub | 05/12/2023 6:44:29 PM |
Bloch bought 10,000 shares at market price $31K. | fantomphan | investorshub | 05/12/2023 12:56:28 PM |
15 years like a lot patience. Why do | ranchhand71 | investorshub | 05/08/2023 8:27:46 PM |
JGR, you state Chan blamed that on the | biotech48 | investorshub | 05/03/2023 6:28:18 PM |
This is beyond remarkable. That she survived all | fantomphan | investorshub | 05/03/2023 12:50:10 PM |
Case of the Month | andy55q | investorshub | 05/03/2023 9:23:55 AM |
Kathy had to leave the call to get | fantomphan | investorshub | 05/02/2023 8:56:35 PM |
Q1 2023 was $9.4 million... | Good Sport | investorshub | 05/02/2023 8:19:48 PM |
Sorry that's one million two hundred thousand dollars | J G R | investorshub | 04/29/2023 1:02:32 PM |
Less than one tenth of that capacity of | J G R | investorshub | 04/28/2023 12:04:23 AM |
no we Harbor6460. I like that he has | biotech48 | investorshub | 04/26/2023 6:24:18 PM |
News, Short Squeeze, Breakout and More Instantly...
CytoSorbents Corporation Company Name:
CTSO Stock Symbol:
NASDAQ Market:
CytoSorbents Corporation Website:
PRINCETON, N.J., July 02, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announced that on...
PRINCETON, N.J., June 24, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announces the reg...
PRINCETON, N.J., June 13, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announces the lau...